Most Read News

Friday's retail sales and industrial output reports should demonstrate whether Beijing's multiple stimulus initiatives are indeed impacting demand.

Losing mid-cap stocks far outnumbered the gaining mid-cap stocks in the month of October 2024

Not only did LIC lag private insurers in NBP, but it also saw the number of policies sold falling precipitously

The FPI selling momentum of October continued in the first week of November, putting pressure on markets

It was reversal of fortunes for the IT sector this week as a renewed effort at US growth saw IT sector picking traction

U.S. West Texas Intermediate crude prices were down 25 cents, or 0.4%, to $70.13 a barrel, while Brent crude futures fell 19 cents, or 0.3%, to $73.68 a barrel.

Jerome Powell has refused to allow political calculations to impact the thinking of the Fed on the rates trajectory

According to a recent Reuters/Ipsos poll, the majority of Americans think Trump would increase the national debt during his next term

Indian benchmark indices likely to open negative on November 11. The GIFT Nifty was trading at 24,129, around 21 points down this morning.

Lupin ranks as the third-largest pharmaceutical player in the U.S. by prescriptions and seventh in the Indian Pharmaceutical Market (IPM).